119 related articles for article (PubMed ID: 3348058)
1. Expression of epithelial membrane antigen on malignant mesothelioma cells. An immunocytochemical and immunoelectron microscopic study.
van der Kwast TH; Versnel MA; Delahaye M; de Jong A; Zondervan PE; Hoogsteden H
Acta Cytol; 1988; 32(2):169-74. PubMed ID: 3348058
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemistry of malignant mesothelioma: OV632 as a marker of malignant mesothelioma.
Delahaye M; Hoogsteden HC; Van der Kwast TH
J Pathol; 1991 Oct; 165(2):137-43. PubMed ID: 1744800
[TBL] [Abstract][Full Text] [Related]
3. Identification of carcinoma cells in ascitic and pleural fluid. Comparison of four panepithelial antigens with carcinoembryonic antigen.
Mezger J; Stötzer O; Schilli G; Bauer S; Wilmanns W
Acta Cytol; 1992; 36(1):75-81. PubMed ID: 1546516
[TBL] [Abstract][Full Text] [Related]
4. The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions.
Hasteh F; Lin GY; Weidner N; Michael CW
Cancer Cytopathol; 2010 Apr; 118(2):90-6. PubMed ID: 20209622
[TBL] [Abstract][Full Text] [Related]
5. The value of epithelial membrane antigen expression in separating benign mesothelial proliferation from malignant mesothelioma: a comparative study.
Saad RS; Cho P; Liu YL; Silverman JF
Diagn Cytopathol; 2005 Mar; 32(3):156-9. PubMed ID: 15690334
[TBL] [Abstract][Full Text] [Related]
6. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
Friedman MT; Gentile P; Tarectecan A; Fuchs A
Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
[TBL] [Abstract][Full Text] [Related]
7. Distinction between carcinoma cells and mesothelial cells in serous effusions. Usefulness of immunohistochemistry.
Tickman RJ; Cohen C; Varma VA; Fekete PS; DeRose PB
Acta Cytol; 1990; 34(4):491-6. PubMed ID: 2197840
[TBL] [Abstract][Full Text] [Related]
8. Immunocytology of body cavity fluids. MOC-31, a monoclonal antibody discriminating between mesothelial and epithelial cells.
Ruitenbeek T; Gouw AS; Poppema S
Arch Pathol Lab Med; 1994 Mar; 118(3):265-9. PubMed ID: 8135629
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived growth factor receptor immunoreactivity in mesothelioma and nonneoplastic mesothelial cells in serous effusions.
Ascoli V; Scalzo CC; Facciolo F; Nardi F
Acta Cytol; 1995; 39(4):613-22. PubMed ID: 7543232
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical properties of malignant mesothelioma cells in histologic and cytologic specimens.
Motoyama T; Watanabe T; Okazaki E; Tanaka N; Watanabe H
Acta Cytol; 1995; 39(2):164-70. PubMed ID: 7534025
[TBL] [Abstract][Full Text] [Related]
11. Malignant ascites of serous papillary ovarian adenocarcinoma. An immunocytochemical study of the tumor cells.
Guzman J; Hilgarth M; Bross KJ; Ross A; Wiehle U; Kresin V; Grunert F; von Kleist S
Acta Cytol; 1988; 32(4):519-22. PubMed ID: 3041721
[TBL] [Abstract][Full Text] [Related]
12. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions.
Shield PW; Koivurinne K
Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095
[TBL] [Abstract][Full Text] [Related]
13. The value of the immunoperoxidase slide assay in the diagnosis of malignant pleural effusions in breast cancer.
Guzman J; Costabel U; Bross KJ; Wiehle U; Grunert F; Schaefer HE
Acta Cytol; 1988; 32(2):188-92. PubMed ID: 3279712
[TBL] [Abstract][Full Text] [Related]
14. Immunoperoxidase staining of malignant cells in pleural effusions.
Pastormerlo M
Pathologica; 1990; 82(1080):421-5. PubMed ID: 2284143
[TBL] [Abstract][Full Text] [Related]
15. Expression of platelet-derived growth factor (PDGF) and PDGF receptors in human malignant mesothelioma in vitro and in vivo.
Langerak AW; De Laat PA; Van Der Linden-Van Beurden CA; Delahaye M; Van Der Kwast TH; Hoogsteden HC; Benner R; Versnel MA
J Pathol; 1996 Feb; 178(2):151-60. PubMed ID: 8683381
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical localization of prekeratin filaments in benign and malignant cells in effusions. Comparison with intermediate filament distribution by electron microscopy.
Kahn HJ; Hanna W; Yeger H; Baumal R
Am J Pathol; 1982 Nov; 109(2):206-14. PubMed ID: 6182803
[TBL] [Abstract][Full Text] [Related]
17. Immunocytochemistry in the differential diagnosis of effusions: use of logistic regression to select a panel of antibodies to distinguish adenocarcinomas from mesothelial proliferations.
Frisman DM; McCarthy WF; Schleiff P; Buckner SB; Nocito JD; O'Leary TJ
Mod Pathol; 1993 Mar; 6(2):179-84. PubMed ID: 8483888
[TBL] [Abstract][Full Text] [Related]
18. Application of immunocytochemistry to the cytologic study of peritoneal fluids in patients with ovarian cancer.
Shinozuka T; Ebisawa K; Miyamoto T; Murakami M; Fujii A; Osamura Y
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Oct; 43(10):1355-62. PubMed ID: 1955789
[TBL] [Abstract][Full Text] [Related]
19. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids.
Politi E; Kandaraki C; Apostolopoulou C; Kyritsi T; Koutselini H
Diagn Cytopathol; 2005 Mar; 32(3):151-5. PubMed ID: 15690338
[TBL] [Abstract][Full Text] [Related]
20. Detection of tumor cells in body cavity fluids by flow cytometric and immunocytochemical analysis.
Krishan A; Ganjei-Azar P; Jorda M; Hamelik RM; Reis IM; Nadji M
Diagn Cytopathol; 2006 Aug; 34(8):528-41. PubMed ID: 16850481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]